Michael Fillitz

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Prognostic Factors

Placebo Controlled

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Ivanov, Jelena D M Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Michael Willman, Georg Greiner, Katharina Slavnitsch, Emir Hadzijusufovic, Thomas Rülicke, Maik Dahlhoff, Gregor Hoermann, Sigrid Machherndl-Spandl, Gregor Eisenwort, Michael Fillitz, Thamer Sliwa, Maria-Theresa Krauth, Peter Bettelheim, Wolfgang R Sperr, Elisabeth Koller, Michael Pfeilstöcker, Heinz Gisslinger, Felix Keil, Robert Kralovics, Peter Valent
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms. American journal of hematology (2023)
Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz, Shirley D'Sa, Ronwyn Cartwright, Frank Shafer, Marek Wardȩcki, Jennifer Wang, Christian Schoergenhofer, Bernd Jilma
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial. British journal of haematology 198 (4) (2022)